semaglutide injections davis ca just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Compounded Semaglutide GLP-1 for Weight

Always consult your GP as the first point of contact to explore what support is available to you

Get started with your Tirzepatide weight loss journey We start with a comprehensive medical evaluation, develop your tailored Tirzepatide treatment plan, and offer ongoing support to enhance your weight loss outcomes

Compounded semaglutide may still be available, but it is no longer legally allowed to be a copy of Wegovy

In Dec 2021, Shanghai Innogen Pharma successfully completed a $120 million Series A funding round to support its Phase III trial of supaglutide, a GLP-1 agonist targeting diabetes

This positive effect may become more apparent as treatment progresses and weight loss accumulates

Kaihara KA, Dickson LM, Jacobson DA, Tamarina N, Roe MW, Philipson LH, et al